Analysts foresee more revenue Morphosys

Tomorrow the German Morphosys will report its past quarters results. Over the current book year the company from Planegg could achieve a revenue around 325.39 million euros (consensus estimates). This is quite more than 2020's revenue of 71.76 million euros.

Historical revenues and results Morphosys plus estimates 2020

fundamenteel onderzoek

The analysts expect for 2021 a net profit of 24 million euros. For this year the consensus of Morphosys 's result per share is a profit of 78 cent. The price/earnings-ratio therefore equals a very high 109.26.

Analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is a low 0.37 percent.

Based on the current number of outstanding shares Morphosys 's market capitalization 2.69 billion euros. The Morphosys stock was the past 12 months quite unstable. Since last March the stock is 6 percent higher. This year the stock price moved between 65 and 125 euro.

Historical stock prices Morphosys from 2007 till 2021

stock price morphosys

Click here for dividend Morphosys. On Friday the stock closed at 85.22 euros.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.